PL3438651T3 - Zastosowania substancji markerów - Google Patents
Zastosowania substancji markerówInfo
- Publication number
- PL3438651T3 PL3438651T3 PL18190951.6T PL18190951T PL3438651T3 PL 3438651 T3 PL3438651 T3 PL 3438651T3 PL 18190951 T PL18190951 T PL 18190951T PL 3438651 T3 PL3438651 T3 PL 3438651T3
- Authority
- PL
- Poland
- Prior art keywords
- marker substances
- marker
- substances
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/4625—Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- High Energy & Nuclear Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Data Mining & Analysis (AREA)
- General Physics & Mathematics (AREA)
- Signal Processing (AREA)
- Software Systems (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010038014.8A DE102010038014B4 (de) | 2010-10-06 | 2010-10-06 | Verwendung spezifischer Substanzen als Marker zur Bestimmung des Risikos einer Nierenabstoßung |
| US39131710P | 2010-10-08 | 2010-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3438651T3 true PL3438651T3 (pl) | 2024-02-26 |
Family
ID=45872140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18190951.6T PL3438651T3 (pl) | 2010-10-06 | 2011-10-05 | Zastosowania substancji markerów |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10497465B2 (pl) |
| EP (2) | EP2625511B1 (pl) |
| AU (1) | AU2011311596B2 (pl) |
| CA (1) | CA2813863A1 (pl) |
| DE (1) | DE102010038014B4 (pl) |
| ES (1) | ES2963482T3 (pl) |
| HU (1) | HUE064419T2 (pl) |
| PL (1) | PL3438651T3 (pl) |
| WO (1) | WO2012045773A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012205686B3 (de) * | 2012-04-05 | 2013-08-01 | Numares Gmbh | Verfahren zur Substanzidentifizierung und zugehöriges Computerprogrammprodukt |
| US9483611B2 (en) | 2012-04-27 | 2016-11-01 | Liposcience, Inc. | Protective HDL particle number evaluations |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| JP6063367B2 (ja) * | 2012-12-04 | 2017-01-18 | 本田技研工業株式会社 | エポキシ樹脂の混練分散性評価方法 |
| KR101686005B1 (ko) * | 2015-02-02 | 2016-12-13 | 삼성전자주식회사 | 자기 공명 영상 장치 및 상기 자기 공명 영상 장치를 이용한 자기 공명 분광법 |
| CN109891259B (zh) | 2016-12-22 | 2022-04-15 | 诺码锐思股份公司 | 确定分析系统正常运行的方法和执行该方法的对照组合物 |
| CN115754308A (zh) * | 2017-03-15 | 2023-03-07 | 诺码锐思股份公司 | 用于确定肾排斥风险的标志物组的用途 |
| US11328346B2 (en) | 2019-06-24 | 2022-05-10 | International Business Machines Corporation | Method, system, and computer program product for product identification using sensory input |
| CN113176364A (zh) * | 2021-04-19 | 2021-07-27 | 中国医学科学院北京协和医院 | 一种同时检测氧化三甲胺和苯乙酰谷氨酰胺的方法及其检测试剂盒和应用 |
| EP4740015A1 (en) | 2023-07-06 | 2026-05-13 | Numares AG | Use of a marker set for determining the risk of an individual to have hepatocellular carcinoma |
| EP4740022A1 (en) | 2023-07-06 | 2026-05-13 | Numares AG | Use of a biomarker for determining the risk of an individual to have hepatic encephalopathy |
| WO2025008464A2 (en) | 2023-07-06 | 2025-01-09 | Numares Ag | Use of a marker or a marker set for determining the risk of an individual to have ascites |
| EP4739389A2 (en) | 2023-07-06 | 2026-05-13 | Numares AG | Use of a marker or a marker set for determining the risk of an individual to have a reduced liver function |
| EP4740021A2 (en) | 2023-07-06 | 2026-05-13 | Numares AG | Use of a biomarker for determining the child-pugh class into which an individual is to be classified |
| DE102023125870A1 (de) | 2023-09-25 | 2025-03-27 | Numares Ag | Verwendung eines Markersets für die Diagnostik des Prostatakarzinoms |
| DE102023125871A1 (de) | 2023-09-25 | 2025-03-27 | Numares Ag | Verwendung eines Markersets zur Bestimmung des Risikos von Blasenkrebs haben oder entwickeln |
| DE102023125865A1 (de) | 2023-09-25 | 2025-03-27 | Numares Ag | Verwendung eines Markersets zur Ermittlung des Risikos der Entwicklung von kastrationsresistentem Prostatakrebs |
| DE102023125866A1 (de) | 2023-09-25 | 2025-04-10 | Numares Ag | Verwendung eines Markersets zur Ermittlung der Aggressivität eines Prostatatumors |
| DE102023125869A1 (de) | 2023-09-25 | 2025-03-27 | Numares Ag | Verwendung eines Markersets zur Unterscheidung zwischen einem Prostatakarzinom und eine guteartige Prostataveränderung |
| EP4734120A1 (en) * | 2024-10-24 | 2026-04-29 | Roche Diagnostics GmbH | Method of sample identification, sample processing system, and non-transitory storage medium |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4689564A (en) | 1985-06-10 | 1987-08-25 | General Electric Company | Digital interface subsystem for a magnetic resonance imaging and spectroscopy system |
| DE19727879A1 (de) | 1997-06-30 | 1999-02-04 | Gsf Forschungszentrum Umwelt | Verfahren zur Bestimmung der Anzahl von Komponenten in Peaks, Banden und Signalen von Chromatogrammen, Elektrogrammen und Spektrogrammen aller Art |
| IL143892A0 (en) | 1998-12-21 | 2002-04-21 | Univ Monash | Kidney disease detection and treatment |
| US6584413B1 (en) | 2001-06-01 | 2003-06-24 | Sandia Corporation | Apparatus and system for multivariate spectral analysis |
| EP1425695A2 (en) * | 2001-08-13 | 2004-06-09 | Beyong Genomics, Inc. | Method and system for profiling biological systems |
| US7457708B2 (en) * | 2003-03-13 | 2008-11-25 | Agilent Technologies Inc | Methods and devices for identifying related ions from chromatographic mass spectral datasets containing overlapping components |
| US20090093010A1 (en) | 2004-09-21 | 2009-04-09 | University Of Manitoba | Method of Detecting Kidney Dysfunction |
| DE102005026133B4 (de) | 2005-06-01 | 2008-08-07 | Gematria Test Lab Gmbh | Verfahren zur Bestimmung der antioxidativen Aktivität von Stoffen und Stoffgemischen |
| DE102009032649B4 (de) * | 2009-07-10 | 2017-12-21 | Bruker Daltonik Gmbh | Massenspektrometrische Identifizierung von Mikroben nach Unterarten |
-
2010
- 2010-10-06 DE DE102010038014.8A patent/DE102010038014B4/de active Active
-
2011
- 2011-10-05 HU HUE18190951A patent/HUE064419T2/hu unknown
- 2011-10-05 AU AU2011311596A patent/AU2011311596B2/en not_active Ceased
- 2011-10-05 ES ES18190951T patent/ES2963482T3/es active Active
- 2011-10-05 EP EP11778815.8A patent/EP2625511B1/en active Active
- 2011-10-05 WO PCT/EP2011/067383 patent/WO2012045773A1/en not_active Ceased
- 2011-10-05 CA CA2813863A patent/CA2813863A1/en not_active Abandoned
- 2011-10-05 PL PL18190951.6T patent/PL3438651T3/pl unknown
- 2011-10-05 EP EP18190951.6A patent/EP3438651B1/en active Active
- 2011-10-05 US US13/878,094 patent/US10497465B2/en active Active
-
2019
- 2019-10-16 US US16/654,828 patent/US20200051669A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20130289887A1 (en) | 2013-10-31 |
| EP3438651B1 (en) | 2023-09-13 |
| AU2011311596A1 (en) | 2013-05-02 |
| WO2012045773A9 (en) | 2012-10-18 |
| US20200051669A1 (en) | 2020-02-13 |
| DE102010038014A1 (de) | 2012-04-12 |
| CA2813863A1 (en) | 2012-04-12 |
| US10497465B2 (en) | 2019-12-03 |
| WO2012045773A1 (en) | 2012-04-12 |
| EP2625511A1 (en) | 2013-08-14 |
| AU2011311596B2 (en) | 2015-12-24 |
| DE102010038014B4 (de) | 2021-10-07 |
| ES2963482T3 (es) | 2024-03-27 |
| EP3438651A2 (en) | 2019-02-06 |
| EP3438651A3 (en) | 2019-04-17 |
| EP2625511B1 (en) | 2018-08-29 |
| HUE064419T2 (hu) | 2024-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE064419T2 (hu) | Marker anyagok alkalmazásai | |
| IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
| GB201006699D0 (en) | Composition | |
| SMT202200034T1 (it) | Composizione farmaceutica di carbetocina | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| PT2531518T (pt) | Compostos oligopeptídicos e suas utilizações | |
| GB201006178D0 (en) | Composition | |
| EP2524296A4 (en) | EXTENDING THE VISUALIZATION FUNCTIONALITY OF AN APPLICATION | |
| SI2407155T1 (sl) | Preparati na osnovi inekalcitola | |
| GB201006214D0 (en) | Composition | |
| GB201006204D0 (en) | Composition | |
| GB201004717D0 (en) | Composition | |
| GB201002233D0 (en) | Use of novel materials in marker systems | |
| GB201014687D0 (en) | Tile marker | |
| GB201010657D0 (en) | Composition | |
| GB201006175D0 (en) | Composition | |
| GB201006012D0 (en) | Composition | |
| GB201002356D0 (en) | Composition | |
| GB201015913D0 (en) | Marker | |
| GB201002114D0 (en) | Marker | |
| GB201002115D0 (en) | Marker | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| GB201011497D0 (en) | Page marker | |
| ZA201000981B (en) | Use of novel materials in marker systems | |
| TWM386865U (en) | Residue-filtering structure of juice-extractor |